Home›Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen›Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen + Cidofovir

Does Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen Interact with Cidofovir?

Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen and Cidofovir have a unknown drug interaction according to U.S. FDA drug labeling data. Some examples of drugs that are eliminated by active tubular secretion include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.5) ] . Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen and your doctor is considering prescribing Cidofovir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen(Odefsey)+💊 Cidofovir

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Drug B class
—
Source
FDA drug label - emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide

What this means in plain English

Some examples of drugs that are eliminated by active tubular secretion include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.5) ] .

About Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen and Cidofovir

Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen is a Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor. Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen is also sold under the brand name Odefsey. Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen is taken by mouth, whereas Cidofovir is given by intravenous (IV) infusion. Both Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen and Cidofovir carry an FDA boxed warning — the agency's most serious safety designation.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Emtricitabine Rilpivirine Hydrochloride And Tenofovir Alafen and Cidofovir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.